Drupal.behaviors.print = function(context) {window.print();window.close();}>
Vermillion's Q2 Revenues Rise on Increased OVA1 Sales
August 15, 2012
Vermillion's Q2 Revenues Rise on Increased OVA1 Sales
By
a GenomeWeb staff reporter
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
Vermillion's OVA1 Sales Increase 8 Percent in Q1
May 16, 2013 / GenomeWeb Daily News
Vermillion Posts $413K in Q3 Revenues, Inks New Deal with Quest
November 11, 2010 / GenomeWeb Daily News
Vermillion to Raise up to $31.5M in Equity Financing
May 9, 2013 / GenomeWeb Daily News
Nanosphere Q1 Revenues Rise 85 Percent; Secures $27M in Financing
May 8, 2013 / GenomeWeb Daily News
US Diagnostics Business Drives up Meridian Bioscience Q1 Revenues 13 Percent
January 23, 2013 / GenomeWeb Daily News